Pharmalot… Pharmalittle… Good Evening
1 CommentBy Ed Silverman // September 6th, 2007 // 5:44 pm
This was an exceptionally busy day, what with our exclusive news about Vioxx clinical trials (please see this) and still more controversy over antidepressants (please take our poll). Now, though, we must adjourn for a dinner engagement. We look forward to engaging you again tomorrow. Meanwhile, please enjoy these….
Biogen Idec Forecasts Profit Surge On Tysabri Demand (Bloomberg News)
Par Pharmaceutical Reports Long-Delayed Financial Results (Yahoo/Reuters)
IMS Health Exec Predicts Rosy Future For Generics (Yahoo/AP)
Corporate Venture Capital Investing Grows Significantly (Pacific Business News)
Carmelo Lisciotto
Interesting news…
Carmelo Lisciotto